IRIS Accounts Production v25.1.3.33 SC499477 Board of Directors Board of Directors 1.4.24 31.3.25 31.3.25 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC4994772024-03-31SC4994772025-03-31SC4994772024-04-012025-03-31SC4994772023-03-31SC4994772023-04-012024-03-31SC4994772024-03-31SC499477ns15:Scotland2024-04-012025-03-31SC499477ns14:PoundSterling2024-04-012025-03-31SC499477ns10:Director12024-04-012025-03-31SC499477ns10:Director22024-04-012025-03-31SC499477ns10:PrivateLimitedCompanyLtd2024-04-012025-03-31SC499477ns10:Micro-entities2024-04-012025-03-31SC499477ns10:AuditExemptWithAccountantsReport2024-04-012025-03-31SC499477ns10:FullAccounts2024-04-012025-03-31SC499477ns5:CurrentFinancialInstruments2025-03-31SC499477ns5:CurrentFinancialInstruments2024-03-31SC499477ns10:RegisteredOffice2024-04-012025-03-31
REGISTERED NUMBER: SC499477 (Scotland)















Unaudited Financial Statements for the Year Ended 31 March 2025

for

Cademuir Pharma Services Limited

Cademuir Pharma Services Limited (Registered number: SC499477)






Contents of the Financial Statements
for the Year Ended 31 March 2025




Page

Balance Sheet 1

Chartered Accountant's Report 3

Cademuir Pharma Services Limited (Registered number: SC499477)

Balance Sheet
31 March 2025

31.3.25 31.3.24
£    £    £    £   
FIXED ASSETS 4,417 3,052

CURRENT ASSETS 122,581 127,075

CREDITORS
Amounts falling due within one year (84,159 ) (82,057 )
NET CURRENT ASSETS 38,422 45,018
TOTAL ASSETS LESS CURRENT
LIABILITIES

42,839

48,070

CAPITAL AND RESERVES 42,839 48,070

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

Cademuir Pharma Services Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address are as below:

Registered number: SC499477

Registered office: 6 School Brae
Peebles
EH45 8AT

The presentation currency of the financial statements is the Pound Sterling (£).


2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 2 (2024 - 2 ) .



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Cademuir Pharma Services Limited (Registered number: SC499477)

Balance Sheet - continued
31 March 2025


The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 13 June 2025 and were signed on its behalf by:




Z Pawlak - Director



Mrs K L Pawlak - Director


Chartered Accountant's Report to the Board of Directors
on the Unaudited Financial Statements of
Cademuir Pharma Services Limited

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement is not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, I have prepared for your approval the financial statements of Cademuir Pharma Services Limited for the year ended 31 March 2025 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given me.

As a practising member of ICAS, I am subject to its ethical and other professional requirements which are detailed at https://icas.com/icas-framework-preparation-of-accounts.

This report is made solely to the Board of Directors of Cademuir Pharma Services Limited, as a body, in accordance with my terms of engagement. My work has been undertaken solely to prepare for your approval the financial statements of Cademuir Pharma Services Limited and state those matters that I have agreed to state to the Board of Directors of Cademuir Pharma Services Limited, as a body, in this report in accordance with the requirements of ICAS as detailed at https://icas.com/icas-framework-preparation-of-accounts. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the company and its Board of Directors, as a body, for my work or for this report.

It is your duty to ensure that Cademuir Pharma Services Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Cademuir Pharma Services Limited. You consider that Cademuir Pharma Services Limited is exempt from the statutory audit requirement for the year.

I have not been instructed to carry out an audit or a review of the financial statements of Cademuir Pharma Services Limited. For this reason, I have not verified the accuracy or completeness of the accounting records or information and explanations you have given to me and I do not, therefore, express any opinion on the statutory financial statements.






Gall Robertson CA
Tweedside Park
Tweedbank
Galashiels
Selkirkshire
TD1 3TE


13 June 2025